Key Highlights
- Henry Schein to acquire Acentus, a leading supplier of Continuous Glucose Monitors (CGMs).
- Acquisition aligns with Henry Schein’s strategic growth in the homecare medical supplies market.
- Combined homecare platform revenue to reach approximately $350 million annually.
- Transaction expected to close in Q1 2025; terms remain undisclosed.
- Acentus leadership to join Henry Schein, bringing extensive expertise.
Source: Business Wire
Notable Quotes
- “As the delivery of health care in the U.S. is increasingly provided in home-based settings, Henry Schein is strategically expanding our offerings to meet the growing demand.” — Stanley M. Bergman, Chairman and CEO at Henry Schein, Inc
- “We are delighted to partner with Henry Schein and further our efforts to provide accessible disposable medical supplies to the thousands of individuals nationwide who rely on these products to manage their chronic conditions.” — Todd Cianfrocca, CEO at Acentus
SoHC's Take
Henry Schein’s acquisition of Acentus underscores its commitment to dominating the homecare medical supply market, particularly in providing solutions for chronic condition management like CGMs. By integrating Acentus into its growing portfolio, Henry Schein not only expands its reach but positions itself as a pivotal player in the evolving healthcare landscape, where home-based care is increasingly prioritized. This move ensures a competitive edge while addressing the needs of an aging population and the rising prevalence of chronic conditions.
